Clearance Summary
QCA (VERSION 3.1) received FDA 510(k) clearance under submission number K031363, sponsored by Cell Analysis, Inc.. The device was reviewed via the Abbreviated premarket notification pathway and assigned to the Hematology review panel. The statutory decision date of record is 2004-02-05.
- Submission: K031363
- Applicant / Sponsor: Cell Analysis, Inc.
- Clearance pathway: Abbreviated
- Review panel: Hematology
- Device class: Class II
- Regulation citation: 21 CFR 864.1860
- Decision date: 2004-02-05
Classification & Regulation
This clearance is catalogued under FDA product code NQN and 21 CFR 864.1860, within the Hematology review panel as a Class II device.